Zacks Investment Research
08 Oct 2026, 13:46 UTC · 1h ago
Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock?
Impact · against what's priced in
Moderna's entry into the Nasdaq-100 provides a short-term technical catalyst via passive index inflows, while the oncology trial results are already fully reflected in the current stock price. Merck and Skydance see no material fundamental impact from these announcements.
- MRNA+0.40
Not in the price yet
- In context
While the market has already paid for the oncology platform validation, the mandatory buying triggered by joining the Nasdaq-100 on Oct. 9 is a new technical catalyst not captured in the fundamental valuation.
What MRNA's price assumes · Sep 11
Top 1 mover · tap to explore
